Join
Live feed
·
INSIDERFilingvia Quantisnow
Aytu BioPharma Inc. logo

Chief Executive Officer Disbrow Joshua R. was granted 30,000 shares, increasing direct ownership by 14% to 237,203 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AYTU· Aytu BioPharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AYTU (Aytu BioPharma Inc.) and more on Quantisnow.